Skip to main content

Two Sigma Xi Grant-in-Aid of Research Awards for finding new retinal-degeneration drugs


In June 2019, Emre Coskun and Rebecca James from the Leung lab were each awarded a Sigma Xi Grant-in-Aid of Research, a very competitive grant program for undergraduate students. Both Emre and Becca participate in the lab’s core research on finding new drugs for retinal degeneration. In their projects, Emre and Becca expose zebrafish larvae with retinal-degeneration to different drug compounds. They then evaluate how much each drug can improve the vision of the retinal-degeneration larvae. In Emre’s proposal, he will screen a library of drugs that modulate apoptosis/program cell death to find drugs that may stop retinal cells from dying. In Becca’s proposal, she will screen a library of drugs that are approved by the Food and Drug Administration (FDA) for treating other human diseases. If an FDA-approved drug is also effective on retinal degeneration, it can be prescribed off label to the patients at the doctor’s discretion. Becca’s and Emre’s projects are supervised by Logan Ganzen, a graduate student in our lab who led our drug-screening effort. In recognition of their achievements, Becca and Emre are also nominated to become an associate member of Sigma Xi, The Scientific Research Honor Society.

Purdue University Biological Sciences, 915 Mitch Daniels Boulevard, West Lafayette, IN 47907

Main Office: (765) 494-4408   Business Office: (765) 494-4764  Contact Us

© 2024 Purdue University | An equal access/equal opportunity university | Copyright Complaints

Trouble with this page? Disability-related accessibility issue? Please contact the College of Science Webmaster.

Maintained by Science IT